In contrast, GSK-3β activation decreased cell proliferation of breast cancer cells [13], prostate cancer cells [14], and colon cancer cells [15] as well as survival of prostate cancer cells [16], breast cancer cells [17], and colorectal cells [8]. Here, GSK3B is linked to Familial prostate cancer.